Browsing: Editor’s Picks
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Whooping cough cases up 342% since 2023 as U.S. outbreak continues. What to know about symptoms and spread
The Centers for Disease Control and Prevention had preliminarily documented more than 17,600 whooping cough infections in the U.S. as…
Moody’s downgrades 7 French banks as the country’s debt and political chaos looks set to spill into 2025
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Mom of Elon Musk wants people to have kids even if they can’t afford it: ‘Have children, add value to your life’
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Multimillionaire Lucy Guo’s only regret: Investing in ‘every startup that’s gone to zero’
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Google announces Debbie Weinstein as new EMEA President to “unlock AI growth that benefits everyone”
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Moderna pauses its RSV vaccine trial for children after 5 infants are hospitalized in latest challenge of treating disease
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
German giant Volkswagen bets on upstart Rivian to save its flailing EV software strategy
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…